News & Events

January 18, 2022

Non-Drug, Non-Invasive, FDA-Cleared Device to Treat OCD

8-minute video interview with BrainsWay President and CEO, Christopher von Jako providing expertise around...

January 13, 2022

We Need a Clearer Understanding of Treatment-Resistant Depression, Experts Say

Dr. Aron Tendler, MD, board-certified psychiatrist and Chief Medical Officer of BrainsWay, shares insights...

January 12, 2022

BrainsWay Announces Multiple Publications of New Real-World OCD Data for its Deep TMS™ System

Positive Data Support the Durability and Cost-Effectiveness of Deep TMS as a Treatment for Obsessive-Compulsive...